Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Finasteride helps with prostate symptoms but may cause sexual side effects.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Metformin is less effective in men with early-onset hair loss.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Plant-derived nanoparticles from Polygoni Multiflori Radix promote hair growth better than Minoxidil by affecting androgen pathways.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Caffeine is beneficial for skin and hair treatments but needs better delivery methods to penetrate deeper skin layers.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

5-Alpha-Reductase Inhibitors can cause negative side effects.

American men are older, more obese, and have longer infertility than Canadian men.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.